A Study of SHR-A2102 Versus Investigator's Choice of Chemotherapy in Patients With Platinum-based Chemotherapy and PD-(L)1 Inhibitor Treatment Failed Recurrent or Metastatic Cervical Cancer
Suzhou Suncadia Biopharmaceuticals Co., Ltd.
Suzhou Suncadia Biopharmaceuticals Co., Ltd.
Jiangsu HengRui Medicine Co., Ltd.
Obstetrics & Gynecology Hospital of Fudan University
Suzhou Zelgen Biopharmaceuticals Co.,Ltd
Evopoint Biosciences Inc.
Hospital Israelita Albert Einstein
Fujian Cancer Hospital
Fudan University
Maastricht Radiation Oncology
Indiana University